Literature DB >> 3123372

Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.

D A Vignali1, Q D Bickle, M G Taylor, G Tennent, M B Pepys.   

Abstract

In vivo depletion of C3 with cobra venom factor (CoF) was used to demonstrate the participation of complement in the innate immunity to S. mansoni and in the acquired immunity of both actively and passively immunized rats. Complement was shown to play an important role in innate immunity, being more involved later in larval migration (Days 8-13 post-infection) than at earlier times (Days--1-3 and Days 3-8 post-infection). Furthermore, the specific component of immunity conferred by immune serum transferred at the lung-migration stage also required complement for optimal expression. This supports the notion that both innate and acquired immunity act not against the much studied early post-penetration stages, but primarily against the lung stages. Although decomplementation at earlier stages of parasite migration (up to 3 days post-infection) did cause some reduction of innate immunity, there was no evidence of any effect on the levels of resistance actively induced by exposure to irradiated cercariae. This suggests that, while complement may play a role in innate immunity during the skin-migration phase, specific complement-mediated attrition does not play a crucial role at this time. The situation was very different in the mouse model, since no involvement of complement in either innate or irradiated vaccine-induced immunity could be demonstrated within the first 15 days of infection. Thus, there appear to be phases in the parasite migration in rats, but not in mice, during which complement becomes a critical factor in both innate and acquired immunity to S. mansoni.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123372      PMCID: PMC1454688     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  The cellular and humoral immune response to Schistosoma mansoni infections in inbred rats. I. Mechanisms during initial exposure.

Authors:  M Phillips; W A Reid; J I Bruce; K Hedlund; R C Colvin; R Campbell; C L Diggs; E H Sadun
Journal:  Cell Immunol       Date:  1975-09       Impact factor: 4.868

2.  Complement-dependent adherence of mast cells to schistosomula.

Authors:  A Sher
Journal:  Nature       Date:  1976-09-23       Impact factor: 49.962

3.  Complement activation by parasites. A review.

Authors:  F Santoro; J Bernal; A Capron
Journal:  Acta Trop       Date:  1979-03       Impact factor: 3.112

4.  Combined in vitro effects of rat antibody and neutrophilic leukocytes on schistosomula of Schistosoma mansoni.

Authors:  D A Dean; R Wistar; K D Murrell
Journal:  Am J Trop Med Hyg       Date:  1974-05       Impact factor: 2.345

5.  The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro.

Authors:  J A Clegg; S R Smithers
Journal:  Int J Parasitol       Date:  1972-03       Impact factor: 3.981

6.  Schistosoma mansoni: complement-mediated cytotoxic activity in vitro and effect of decomplementation on acquired immunity in mice.

Authors:  C A Tavares; G Gazzinelli; T A Mota-Santos; W Dias Da Silva
Journal:  Exp Parasitol       Date:  1978-12       Impact factor: 2.011

7.  Immunoglobulin and complement receptors on human eosinophils and their role in cellular adherence to schistosomules.

Authors:  E A Ottesen; A M Stanley; J A Gelfand; J E Gadek; M M Frank; T E Nash; A W Cheever
Journal:  Am J Trop Med Hyg       Date:  1977-11       Impact factor: 2.345

8.  Isolation and study of murine C3.

Authors:  M B Pepys; A C Dash; A H Fielder; D D Mirjah
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

9.  Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. I. Demonstration of resistance to reinfection using a model system that involves perfusion of mice within three weeks of challenge.

Authors:  M Doenhoff; Q Bickle; E Long; J Bain; A McGregor
Journal:  J Helminthol       Date:  1978-09       Impact factor: 2.170

10.  Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro.

Authors:  F J Ramalho-Pinto; D J McLaren; S R Smithers
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  8 in total

1.  Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.

Authors:  Lbachir BenMohamed; Radhika Krishnan; Catherine Auge; James F Primus; Don J Diamond
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

2.  Chronic intestinal nematode infection exacerbates experimental Schistosoma mansoni infection.

Authors:  Quentin D Bickle; Julie Solum; Helena Helmby
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 3.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

4.  Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice.

Authors:  Jessica A Ligas; Laura A Kerepesi; Ann Marie Galioto; Sara Lustigman; Thomas J Nolan; Gerhard A Schad; David Abraham
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 5.  Glycoconjugates in host-helminth interactions.

Authors:  Nina Salinger Prasanphanich; Megan L Mickum; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Immunol       Date:  2013-08-28       Impact factor: 7.561

6.  Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepatica.

Authors:  Maria Teresa Ruiz-Campillo; Veronica Molina Hernandez; Alejandro Escamilla; Michael Stevenson; Jose Perez; Alvaro Martinez-Moreno; Sheila Donnelly; John P Dalton; Krystyna Cwiklinski
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

Review 7.  Schistosomiasis Pulmonary Arterial Hypertension.

Authors:  Jean Pierre Sibomana; Aloma Campeche; Roberto J Carvalho-Filho; Ricardo Amorim Correa; Helena Duani; Virginia Pacheco Guimaraes; Joan F Hilton; Biruk Kassa; Rahul Kumar; Michael H Lee; Camila M C Loureiro; Sula Mazimba; Claudia Mickael; Rudolf K F Oliveira; Jaquelina S Ota-Arakaki; Camila Farnese Rezende; Luciana C S Silva; Edford Sinkala; Hanan Yusuf Ahmed; Brian B Graham
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

8.  Experimental animal models of pulmonary hypertension: Development and challenges.

Authors:  Xiao-Han Wu; Jie-Ling Ma; Dong Ding; Yue-Jiao Ma; Yun-Peng Wei; Zhi-Cheng Jing
Journal:  Animal Model Exp Med       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.